The Institute of Molecular and Translational Medicine (IMTM) is dedicated to advancing biomedical research with a focus on understanding human infectious diseases and cancer. With a mission to innovate and develop future medicines, medical devices, and diagnostic tools, IMTM aims to enhance public health through scientific discovery and collaboration. Situated in Olomouc, Czech Republic, the institute fosters private-public partnerships and facilitates international research collaborations to integrate member researchers into global scientific networks.

IMTM offers an array of services, including clinical trials, core facilities, and advanced technologies available for licensing. Their commitment extends to training the next generation of researchers through various academic programs, including bachelor's, master's, and doctoral degrees. Additionally, IMTM actively participates in significant events such as the Czech Annual Cancer Research Meeting, showcasing the latest advancements in cancer research. This vibrant community is driven by a shared vision of saving lives through cutting-edge research and discovery, making IMTM a pivotal player in the biomedical field.